Christopher L. Lotz's most recent trade in Qualigen Therapeutics Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 11, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics Inc | Christopher L. Lotz | Vice President of Finance, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Qualigen Therapeutics Inc | Christopher L. Lotz | Vice President of Finance, CFO | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 16 Apr 2021 | 2,700 | 12,541 | - | 1.9 | 5,022 | Common Stock |